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Abstract: Contemporary structural biology has an in-
creased emphasis on high-throughput methods. Biomo-
lecular simulations can add value to structural biology via
the provision of dynamic information. However, at present
there are no agreed measures for the quality of biomo-
lecular simulation data. In this Letter, we suggest suitable
measures for the quality assurance of molecular dynamics
simulations of biomolecules. These measures are de-
signed to be simple, fast, and general. Reporting of these
measures in simulation papers should become an ex-
pected practice, analogous to the reporting of comparable
quality measures in protein crystallography. We wish to
solicit views and suggestions from the simulation com-
munity on methods to obtain reliability measures from
molecular-dynamics trajectories. In a database which
provides access to previously obtained simulationssfor
example BioSimGrid (http://www.biosimgrid.org/)sthe user
needs to be confident that the simulation trajectory is
suitable for further investigation. This can be provided by
the simulation quality measures which a user would
examine prior to more extensive analyses.
1. OVERVIEW
For the past quarter century, biomolecular simulations have
been adding value to structural biology via the provision of
dynamic information.1 As genomics move from sequencing
to structural and dynamical considerations, and high-
throughput technologies advance from crystallography to
molecular-dynamics (MD) simulation, this process is occur-
ring with vigor. As the bibliometric data in Figure 1 show,
MD simulation of biopolymers is now becoming a routine
technique. To help this maturation process, standardized
practice should be established in the simulation community,
similar to that in crystallography.2,3 It is already regular
practice to print quality measures in a formulaic table in
published articles reporting crystallographic resultssindeed,
it is surprising if such a table is missing, and the referees
would readily reject the manuscript.
We are hereby initiating a discussion on the appropriate
measures of quality and convergence4 for MD simulation
trajectories of biopolymers. The process of calculating these
measures is designed to be automated for large numbers of
trajectories; hence the set of analyses used for this description
should be general, with minimal interaction of a human
curator. The scientist can then use these measures, along with
sensible comparisons with known experimental data (which
we recognize as essential), to decide whether a specific
trajectory is suitable for further investigation. Our purpose
is to solicit feedback from the simulation community with
regard to the analyses we have chosen and to obtain further
suggestions. We invite the community to express their views
on our choices of measures.
We are motivated to do this by our work in building
BioSimGrid,5 a distributed environment for archiving and
analyzing biopolymer simulations. Other similar databases
are emerging6 (personal communications with Valerie Dag-
gett and Modesto Orozco, http://mmb.pcb.ub.es/MODEL/);
these also require some quality-assurance measures. The
BioSimGrid project was implemented to satisfy the growing
demand for the storage of large amounts of simulation data
which is currently being produced within a number of
laboratories. This environment enables the storage and
analysis of large biopolymer MD trajectories, making previ-
ously logistically difficult comparative analyses and data
curation easier. For example, analyzing large numbers of
trajectories distributed across many laboratories has now
become as seamless through BioSimGrid, as if the data were
produced in the same laboratory. Traditionally, timeseries
of millions of degrees-of-freedom are collected in a biomo-
lecular MD simulation, but only a small fraction of these
are presented in the resulting paper, due to the lifetime of
the project. In this scenario, other laboratories may be
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interested in a trajectory of a biomolecule for which MD
has been done, but without a clearinghouse, access is difficult
to obtain. BioSimGrid aims to make the results of large-
scale computer simulations of biomolecules more accessible
to the biological community. As a comprehensive simulation
data-management system with many analysis tools, BioSim-
Grid provides scientists access to trajectories stored through-
out many laboratories, once public availability has been
granted by the owner of the data. An early exemplar
application is comparisons among enzymes of similar active
sites.7
Some may hold the opinion that, based on the motivation
of the scientist carrying out the work, MD simulations may
be split into two categories: equilibrium and nonequilibrium.
The nonequilibrium simulations are those where the scientist
wished to explore unfolding pathways or large conforma-
tional changes not manifest in known crystallographic
structures. The investigations of biomolecular dynamics in
an equilibrium state fall into the other category. It follows
that the quality-assurance measures and analyses methods
for these different classes have to be quite different. We take
a more agnostic approach at the original motivation that
brought the trajectory into existence. There are many types
of MD simulations being performed under varying degrees
of nonequilibrium conditions; any boundaries or distinctions
imposed a priori may turn out inappropriate. Another
drawback of such a priori description is that it requires
speculation about the scientist’s state-of-mind: the decision
reached thus may not always be accurate.
The following quality-assurance measures we introduce
are not restricted to proteins, but any polymers, and may be
readily applied to nucleic acids, sugars (polysaccharides),
and even nonbiological polymers where the monomers can
be clearly identified. To keep our convergence measures
general, so they may be automated, we include all atoms in
each biopolymer within the trajectory, and we perform the
analysis by first performing quaternion least-squares fitting8
for the atoms with respect to the initial configuration of the
stored trajectory. These measures could appropriately be split
into three different classes: quality, convergence, and
structural;9,10 they are described in detail in the sections
below.
2. PROVENANCE METADATA, WHOSE REPORTING
SHOULD BE OBLIGATORY
Two particular sets of metadata that describe the prov-
enance of the trajectory should be reported. The provenance,
or ontogeny, metadata tell how and whence the trajectory
came about. The first concerns the preprocessing before the
initial structure for the MD simulation can be obtained; the
second, the particular setup for the simulation. As is typical
for reporting of experimental procedures in scientific litera-
ture, these should be reported to the extent that an unrelated
laboratory will be able to reproduce the simulation.
The first set, presentable in free-styled text, includes the
following: the Protein Data Bank identification code for the
crystallographic structure on which the simulation is based;
the procedure for reconstructing residues and side chains
which were not observed in the crystallographic structure;
determination of protonation states; ligand insertion; solvation
(including the retention of crystallographic water molecules
and addition of ions) or insertion into medium (for example,
the procedure of solvation in water and that for insertion
Figure 1. Bibliometrics shows that molecular-dynamics simulation has the potential to become a routine scientific technique for investigating
biopolymer dynamics: search results for protein molecular dynamics simulations in Web of Science, Biophysical Journal, UMI ProQuest
Digital Dissertations, and Index to Theses in Great Britain. Web of Science search for protein molecular dynamics simulations “TS )
((molecular SAME dynamics) AND simulation* AND protein*)” at http://wok.mimas.ac.uk/. Title/abstract search in the Biophysical Journal
for keywords ‘molecular dynamics’ and ‘simulation’ at http://www.biophysj.org/. Abstract search ““molecular dynamics” and “protein*””
in the UMI ProQuest Digital Dissertations (mainly North American) at http://wwwlib.umi.com/dissertations/. Search ““molecular dynamics”
and “protein*”” in the Index to Theses in Great Britain (false positives in the 1980s removed) at http://www.theses.com/. Data up-to-date
mid-2004.
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into a lipid bilayer); and the equilibration protocol (including
the preequilibration of solvents and ions).
The second set, mostly presentable in a formulaic table
(Table 1), includes the following: MD software package
(name and version); computer hardware and operating system
used (general timing information if appropriate); force fields
for both solute and solvent (name and version, including any
special modifications); boundary condition and shape of unit
cell; electrostatics treatment; ensemble; barostat (if used:
type and target pressure); thermostat (if used: type and target
temperature); constraints; time-step; snapshot sampling fre-
quency; duration of simulated trajectory; and special re-
straints and interactive MD protocol.
Calls for a standard in the output of MD packages are
particularly poignant here: all the items enumerated in the
second set need to be reported in the entirety to facilitate
comparison; this is not routinely done in the literature. The
most convenient and sensible spot to capture these metadata
is at the point of generation; that is, at the output of the MD
package. However, at the moment, the defaults of each MD
package (which may be different) are often not written out
explicitly and have to be speculated downstream. Capturing
metadata in detail also helps in avoiding inappropriate setup
parameters from being usedsfor example, with the help of
a validating program that alerts the scientist about inap-
propriate combinations of electrostatics treatment and solvent
force field (among others).
3. THERMODYNAMIC MEASURES OF QUALITY,
WHOSE REPORTING SHOULD BE OBLIGATORY
When MD simulations are performed, various quantities
are calculated and written to output files. Some of these are
well-understood and may be used to observe what is
happening in a simulation as an indication of quality. For
instance, we might expect the temperature in a simulation
with a thermostat applied to be fluctuating about a constant
value, within a small range, over time; if this is not the case,
then the quality of the simulation is suspicious. We have
decided that these quality-indicating measures which we
consider should be the following: temperature, pressure,
potential energy, kinetic energy, number density, volume,
cell dimensions, and specific heat capacity. There are some
redundancies in reporting; this is to avoid the need for the
users to recalculate often-used values, but the values also
need to be verified to ensure consistency. “Quality” here
means “overall thermodynamic stability” and does not
necessarily guarantee the simulation’s accuracy in reproduc-
ing physical phenomena or the “usefulness” of the trajec-
tory: Even an ill-parametrized force field can yield to stable
but unphysical trajectories. Further, anomalies may occur due
to local unbalanced distributions of kinetic energy; a careful
human curator, rather than the reported values here, will have
to be relied upon to catch these.
As their behavior is well-understood and they depend on
the simulation conditions, these measures may be called
quality measures for the trajectory. These should be obtained
from the simulation output files, though we note that current
MD packages usually do not write these out for every time-
step by default; this arguably should be rectified to avoid
data loss. These quantities should be plotted as a time-series.
The mean and standard deviation should be reported, so
automatic filters can be easily applied downstream to select
only the trajectories over a quality threshold.
4. CONVERGENCE AND FLUCTUATION MEASURES,
WHOSE REPORTING SHOULD BE OBLIGATORY
Once the quality of the simulation has been determined
by examining the thermodynamic measures, it is instructive
to inspect some measures that reflect the convergence and
the fluctuations. As not all simulations are meant to be
converging, these are not necessarily measures of the quality,
but unexpected behaviors can lead to interesting investiga-
tions or possible problems. These useful measures are the
root-mean-square deviation and fluctuation and the radius
of gyration.
The root-mean-square deviation (RMSD) time-series
throughout a trajectory can be used to understand by how
much the conformation of a biopolymer changes with respect
to time. The RMSD provides a measure of conformational
stability or drift. For a converging simulation, we would
expect the RMSD to increase and then start to plateau.
(However, RMSD plateauing does not necessarily indicate
convergence.) As we wish the same analysis to be performed
automatically, we want a set of basic, specific rules that can
be adhered to. First, all atoms in the biopolymer molecule
are used in the least-squares fitting procedure to remove the
translational and rotational degrees of freedom. The RMSD
is calculated with respect to the initial configuration in the
trajectory, and all atoms are used to calculate the RMSD. In
addition, it may be useful to report RMSD for only the
backbone or R-carbon atoms of proteins or to exclude some
loops with large fluctuations in RMSD calculations.
The root-mean-square fluctuation (RMSF), like the RMSD,
is calculated for all atoms in each biopolymer. Before this
calculation, all atoms included in the trajectory are used to
remove the translational and rotational degrees of freedom.
Table 1: Formulaic Table Providing Some of the
Provenance Metadata for a Molecular-Dynamics
Simulation11
global trajectory identifier BioSimGrid_GB-OXF_9
trajectory name outer-membrane phospholipase A
trajectory type membrane-bound protein
method molecular dynamics
time-step 2 fs
sampling frequency 10 ps
total number of frames 566
computational platform commodity Intel-based personal computer
software package GROMACS 2.0
ensemble NpT (isothermal-isobaric)
thermostat Berendsen, 298 K
thermostat relax time 0.1 ps
barostat Berendsen (anisotropic), 100 kPa
barostat relax time 1.0 ps
boundary condition periodic
unit cell cuboid
force field GROMOS87
solvent water
solvent force field SPC
electrostatics treatment cutoff, 1.8 nm
source Protein Data Bank
identifier
1QD5
enzyme classification 3.1.1.32
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The RMSF gives a measure of the fluctuation of atoms
around the average position, and any large fluctuations should
be understood in light of the crystallographic B factors.9,12
The radius of gyration gives a measure of how the mass
of a group of atoms is distributed around their center of mass.
For converged trajectories, the radius of gyration time-series
of a biopolymer should also reach a plateau.
Further convergence measures such as the cosine con-
tent10,14 and overlap measures from block (“windowed”)
analyses15,16 can be obtained from principal component
analysis. For example, comparison of the first and last parts
of a trajectory might help to detect inadequacies in equilibra-
tion or convergence that calls for a longer simulation time.
If desirable, the obligation to report these will emerge from
the simulation community.
5. STRUCTURAL MEASURES, WHOSE REPORTING IS
NOT OBLIGATORY BUT INFORMATIVE
A plot of eigenvalues from principal component analysis,
ranked in decreasing magnitude, should usually shows a
“scree” shape; that is, an initial sharp drop in magnitude
followed by a leveling of small eigenvalues. This indicates
that only a few modes of motions have large length-scales,
as the magnitudes of the eigenvalues tell the contribution to
the total motion from the corresponding principal component.
From this plot the appropriateness of the “essential dynamics”
analysis,13 where only the motion modes with the largest
length-scales receive attention, may be determined. As the
motion of all the constituent atoms is to be determined the
mass-weighted covariance matrix14 is used for the analysis.
A plot where such a “scree” shape can be seen is shown in
Figure 2.
For each of the few principal components with large
eigenvalues (as shown in the scree plot), it is recommended
to plot a graph of the projection of the trajectory onto the
component as a time-series; here the projection in a particular
principal component shows the degree of sampling within
that component. This plot reveals the global-conformational
“states”, or clusters of the same projections, visited. As the
trajectory becomes longer, previously unvisited states can
become visited (exploration); also, previously visited states
may be visited again (revisiting).
Projections of the trajectory onto a pair of principal
components with large eigenvalues provide a good idea of
the phase-space sampled. With an energy value plotted on
the third axis, this is a way to visualize the energy
landscape.17
An example of the comparison of the projections onto the
two principal components with the largest eigenvalues is
shown in Figure 3. In this example, two distinct regions in
the phase-space have been sampled. It is possible to read
from this graph whether there are revisiting events in some
areas in the phase-space. This may be done by clustering or
block analysis (discussed above); however, this process is
highly dependent on the clustering algorithm, so we do not
consider it to be obligatory. Again, if these are desirable,
the obligation to report these can emerge from the simulation
community.
To obtain more specific information on the structure of
the biopolymers, it is advisable to perform analyses designed
for the type of biopolymer in question. For example,
secondary-structure determination over the trajectory can be
done for proteins,18 or the Curves analysis set for nucleic
acids.19 These may provide a more detailed picture on the
quality of the simulation. In addition, quality indices used
by the crystallography, nuclear magnetic resonance, and
bioinformatics communities may be considered to comple-
ment the indices here.20
6. CONCLUSION
In this Letter, we have suggested a scheme where a general
understanding of a biosimulation trajectory may be obtained,
with a set of strictly defined analyses. This set gives the
researcher a reasonable overview to decide whether to
investigate further. We have tried to design the analyses to
be as simple and general as possible, while maintaining
enough complexity to understand and distinguish the simula-
tions.
We have implemented these measures in the BioSimGrid
toolkit. This toolkit has been developed to enable users to
perform predefined analyses easily within the analysis
environment. When the archiving of a trajectory is complete,
these analyses will automatically be performed on the
recently deposited data via the standard tools included in
the toolkit.
We consider the set of analyses suggested here to be
adequate and hope that the simulation community will adopt
it as a basis for development and discussion. Suggestions
may be sent to the Editors of this journal or to the authors.
Figure 2. The 20 eigenvalues with the largest magnitude for a
9.6 ns simulation of a prion protein are plotted to obtain a scree
plot to determine the most prominent modes of motion.
Figure 3. Projection of a trajectory for a 9.6 ns simulation of a
prion protein onto the two principal components with the largest
eigenvalues showing the sampling in the first (PC 1) and second
(PC 2) components.
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